Skip to main content
. 2023 Jan 20;14:1121122. doi: 10.3389/fphar.2023.1121122

FIGURE 2.

FIGURE 2

Contrast-enhanced Magnetic Resonance Imaging (MRI) of the upper abdomen showed the patient’s pancreatic carcinoma before (A) and after (B) the treatment of PD-1, HIFU and Gemcitabine. MRI showed the patient’s liver metastasis before (C) and after (D) the treatment. CA199 (E) and carcinoembryonic antigen (CEA) (F) index of the patient.